The adjusted VE against infection of any severity was 58.8% for BNT162b2 and 73.9% for mRNA-1273. Both vaccines maintained high protection in children with underlying medical conditions and reduced ...

Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.

The fall-winter COVID-19 vaccine designed to counter XBB, a subvariant of the Omicron strain, is now available nationwide for ...

The CDC has issued updated recommendations for the 2025–2026 COVID-19 vaccination season, covering mRNA and protein subunit vaccines for people aged 6 months and older. The new formulations target ...

Find the latest covid-19 vaccine news from Fast company. See related business and technology articles, photos, slideshows and ...

Just today, Marty Makary officially resigned his position as head of the Food and Drug Administration. Politico was the first ...

While the world has largely moved past the acute phase of the COVID-19 pandemic, the infectious disease landscape in May 2026 is far from quiet. From the emergence of the 'Cicada' variant and a ...

The Mainz-based biopharmaceutical company BioNTech is halting COVID-19 vaccine production in Germany, closing almost all its ...

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...

How Canada can avoid past mistakes as public health measures ease. People say they want COVID-19 to become 'endemic.' But what does that really mean? Several jurisdictions across the country outlined ...

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.